Literature DB >> 11289094

The BCR gene and philadelphia chromosome-positive leukemogenesis.

E Laurent1, M Talpaz, H Kantarjian, R Kurzrock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11289094

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  26 in total

1.  Bad patients meet good drugs.

Authors:  Juan Carlos Lacal
Journal:  Clin Transl Oncol       Date:  2006-04       Impact factor: 3.405

2.  Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.

Authors:  Rathi N Pillai; Lisa S Chen; Mary L Ayres; Billie J Nowak; Michael W Thomas; Elizabeth J Shpall; Michael J Keating; Varsha Gandhi
Journal:  Leuk Lymphoma       Date:  2012-04-23

3.  Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo.

Authors:  Nidhi Jyotsana; Amit Sharma; Anuhar Chaturvedi; Ramachandramouli Budida; Michaela Scherr; Florian Kuchenbauer; Robert Lindner; Fatih Noyan; Kurt-Wolfram Sühs; Martin Stangel; Denis Grote-Koska; Korbinian Brand; Hans-Peter Vornlocher; Matthias Eder; Felicitas Thol; Arnold Ganser; R Keith Humphries; Euan Ramsay; Pieter Cullis; Michael Heuser
Journal:  Ann Hematol       Date:  2019-05-18       Impact factor: 3.673

4.  Viral/Nonviral Chimeric Nanoparticles To Synergistically Suppress Leukemia Proliferation via Simultaneous Gene Transduction and Silencing.

Authors:  Cheol Am Hong; Soo Kyung Cho; Julius A Edson; Jane Kim; Dominique Ingato; Bryan Pham; Anthony Chuang; David A Fruman; Young Jik Kwon
Journal:  ACS Nano       Date:  2016-08-05       Impact factor: 15.881

5.  FusionPro, a Versatile Proteogenomic Tool for Identification of Novel Fusion Transcripts and Their Potential Translation Products in Cancer Cells.

Authors:  Chae-Yeon Kim; Keun Na; Saeram Park; Seul-Ki Jeong; Jin-Young Cho; Heon Shin; Min Jung Lee; Gyoonhee Han; Young-Ki Paik
Journal:  Mol Cell Proteomics       Date:  2019-06-17       Impact factor: 5.911

6.  BCR-ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR.

Authors:  Antonella Zagaria; Luisa Anelli; Nicoletta Coccaro; Giuseppina Tota; Paola Casieri; Angelo Cellamare; Luciana Impera; Claudia Brunetti; Angela Minervini; Crescenzio Francesco Minervini; Mario Delia; Cosimo Cumbo; Paola Orsini; Giorgina Specchia; Francesco Albano
Journal:  Virchows Arch       Date:  2015-07-07       Impact factor: 4.064

7.  Rapid decline of Philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report.

Authors:  Michele Massimino; Stefania Stella; Elena Tirrò; Maria Letizia Consoli; Maria Stella Pennisi; Adriana Puma; Silvia Rita Vitale; Chiara Romano; Valentina Zammit; Fabio Stagno; Francesco Di Raimondo; Livia Manzella
Journal:  Oncol Lett       Date:  2019-07-04       Impact factor: 2.967

8.  Oridonin in combination with imatinib exerts synergetic anti-leukemia effect in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of LYN/mTOR signaling pathway.

Authors:  Yong Guo; Qingqing Shan; Yuping Gong; Juan Lin; Xi Yang; Ruiqing Zhou
Journal:  Cancer Biol Ther       Date:  2012-08-16       Impact factor: 4.742

Review 9.  Fusion genes and their discovery using high throughput sequencing.

Authors:  M J Annala; B C Parker; W Zhang; M Nykter
Journal:  Cancer Lett       Date:  2013-01-29       Impact factor: 8.679

Review 10.  Chronic myelogenous leukemia in chronic phase.

Authors:  R Kurzrock; H Kantarjian; M Talpaz
Journal:  Curr Treat Options Oncol       Date:  2001-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.